Immunotherapy for Pancreatic Cancer: More Than Just a Gut Feeling

Cancer Discov. 2018 Apr;8(4):386-388. doi: 10.1158/2159-8290.CD-18-0123.

Abstract

<b/> Development of pancreatic cancer in spontaneous murine models is associated with enrichment of specific strains of gut and intratumoral bacteria that induce a tolerogenic immunosuppressive microenvironment favoring cancer progression and resistance to immunotherapies. Ablation of the microbiome with antibiotics reshapes the tumor microenvironment, inducing T-cell activation, improving immune surveillance, and increasing sensitivity to immunotherapy in established tumors. Cancer Discov; 8(4); 386-8. ©2018 AACR.See related article by Pushalkar et al., p. 403.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Animals
  • Cell Transformation, Neoplastic
  • Immunotherapy
  • Mice
  • Microbiota*
  • Pancreatic Neoplasms / immunology*
  • Tumor Microenvironment / immunology